Top Markets
Coin of the day
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Ранг среди акций #25527
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Цена акции
$9.81
Последняя синхронизация: 2025-03-18
Рыночная капитализация
$48.68M
Изменение (1 день)
1.55%
Изменение (1 год)
0.00%
Страна
US
Торговля AlloVir, Inc. (ALVR)

Категория

EPS для AlloVir, Inc. (ALVR)
EPS по состоянию на June 2026 TTM: $-1.71
Согласно последним финансовым отчетам и цене акций AlloVir, Inc., текущий EPS компании (TTM) составляет $-1.71. В конце 2023 EPS компании составлял $-42.09, меньше, чем показателю 2022 года, равному $-50.60.
История EPS компании AlloVir, Inc. с 2018 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-1.71 -85.42%
2024 $-11.73 -72.13%
2023 $-42.09 -16.82%
2022 $-50.60 -19.71%
2021 $-63.02 5.79%
2020 $-59.57 354.39%
2019 $-13.11 71,150.00%
2018 $-0.02 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$17.32 -1,112.87%
US
$27.74 -1,722.22%
NL
$2.98 -274.27%
AU
- -
CH
$-7.98 366.67%
US